Empresa ISR Immune System Regulation Holding AB (publ)
Acciones
ISR
SE0008212195
Biotecnología e investigación médica
Resumen de negocios
Número de empleados: 5
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ola Winqvist
CEO | Chief Executive Officer | 58 | 17/09/15 |
Jonas Winqvist
DFI | Director of Finance/CFO | 55 | 01/01/21 |
Johan Sjodahl
CTO | Chief Tech/Sci/R&D Officer | 52 | 01/01/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chairman | 76 | 01/01/16 | |
Erik Kinnman
BRD | Director/Board Member | 66 | 01/01/22 |
Founder | 77 | 17/09/15 | |
Director/Board Member | 77 | 01/01/22 | |
Director/Board Member | - | 01/01/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 69 008 951 | 48 981 535 ( 70,98 %) | 0 | 70,98 % |
Información de la empresa
ISR Immune System Regulation Holding AB
Retzius väg 11
171 65, Solna
+46 7 05 42 79 39
http://www.israb.se![Dirección ISR Immune System Regulation Holding AB (publ)(ISR)](https://cdn.zonebourse.com/static/address/61747294.png)
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+20,17 % | 126 mil M | |
+24,67 % | 118 mil M | |
+25,44 % | 27,87 mil M | |
-17,74 % | 20,95 mil M | |
-15,17 % | 16,92 mil M | |
-15,21 % | 16,18 mil M | |
+11,91 % | 14,84 mil M | |
-47,10 % | 14,79 mil M | |
+54,50 % | 14,08 mil M |